BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
화요일, 9월 29

Encompass Health Corp

EHCNYSE
Trade with Public
Trade with Public
$124.02
0.550.45%
가까이에: Sep 28, 5:00 PM EST
$124.02
N/A
시간외: 4:00 PM EST
배당금: 배당락일은 내일입니다
개요뉴스실적 전망이벤트목표가재무심리지분 현황배당금비교옵션주식 보고서

Encompass Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Encompass Health (EHC).

Price Target Range — 11 Quarters

Analyst Consensus — 11 Analysts

1S.Buy
10Buy
Consensus RatingBuy# Analysts11Avg. Consensus PT$130Upside to Avg. PT+4.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Aug 10, 2026TD CowenRyan LangstonPT RaiseBuy$125→$140
Aug 7, 2026UBSA.J. RicePT RaiseBuy$150→$155
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $140

TD Cowen analyst Ryan Langston maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $125 to $140.
Benzinga Newsdesk

PRO
UBS Maintains Buy on Encompass Health, Raises Price Target to $155

UBS analyst A.J. Rice maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $150 to $155.
Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Encompass Health, Raises Price Target to $150

Truist Securities analyst David Macdonald maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $140 to $150.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Encompass Health, Raises Price Target to $144

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $140 to $144.
Benzinga Newsdesk

PRO
TD Cowen Initiates Coverage On Encompass Health with Buy Rating, Announces Price Target of $125

TD Cowen analyst Ryan Langston initiates coverage on Encompass Health (NYSE:EHC) with a Buy rating and announces Price Target of $125.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Encompass Health, Lowers Price Target to $140

Barclays analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Overweight and lowers the price target from $153 to $140.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved